Health Condition 1: D508- Other iron deficiency anemias
Conditions
Interventions
Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINES: Participants will receive 1 grain weight of Saccharum lactis impregnated with 2 drops of individualized Homoeopathic medicine, administered once w
Sponsors
White Memorial Homoeo Medical College And Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Young adults aged 20-24 years. Confirmed iron deficiency anemia based on hematological markers (Hemoglobin less than 12 g per dL, serum ferritin less than 15 ng per mL). Residency in the study region (e.g., Kanniyakumari, Tamil Nadu). Those who are eligible for the trial.
Exclusion criteria
Exclusion criteria: Individuals with hemoglobin levels below 7 g per dL who require urgent intervention, such as Intra venous iron or transfusion. Individuals who have chronic diseases affecting iron metabolism, iron absorption, iron overload disorders. Individuals who are taking iron supplements or Homoeopathic remedies for anemia within the past 6 months. Pregnant or Lactating women. Female Participants who have irregular menstrual cycles with menorrhagia or pathologic blood loss (to reduce confounding from chronic loss). Recent major surgery or trauma within the past three months. Use of medications interfering with iron absorption, such as proton pump inhibitors (PPIs) or chronic corticosteroid use. Substance abuse or chronic alcoholism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in serum ferritin level, Symptom resolutionTimepoint: Serum Ferritin - Baseline (Month 0), Month 3 (Week 12), Month 6 (Week 24). Symptom resolution- Monthly intervals: Month 1 (Week 4), Month 2 (Week 8), Month 3 (Week 12), Month 4 (Week 16), Month 5 (Week 20), Month 6 (Week 24). | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of effective Homoeopathic remedies. Treatment adherence. Patient satisfaction. Incidence of side effects. Relapse rateTimepoint: Identification of effective Homoeopathic remedies-Continuous throughout treatment; Final evaluation at Month 6 (Week 24). Treatment adherence - Monthly reviews: Month 1?6 (Weeks 4, 8, 12, 16, 20, 24); Final review at Month 6 (Week 24). Patient satisfaction -Month 3 (Week 12), Month 6 (Week 24). Incidence of side effects-Continuous monitoring; Monthly reviews: Month 1?6 (Weeks 4, 8, 12, 16, 20, 24). Relapse rate-Month 9 (Week 36) ? 3 months post-intervention. | — |
Countries
India
Contacts
Public ContactDr PRIYA RAJINI R M
White Memorial Homoeo Medical College and Hospital
Outcome results
None listed